Wilson Sonsini Goodrich & Rosati acted as Concord Healthcare’s U.S. and Hong Kong counsel in the IPO and SEHK listing. Concord Medical Services Holdings Limited (“Concord...
Concord Healthcare’s $72.2 Million Initial Public Offering
Luzhu Biotechnology’s US$43.4 Million IPO
Wilson Sonsini Goodrich & Rosati acted as U.S. and Hong Kong counsel to the sole sponsor (China International Capital Corporation Hong Kong Securities Limited) and the...
TechStar Acquisition Corporation’s $128.5 Million Hong Kong Listing
Wilson Sonsini, Sidley Austin and Maples and Calder assisted TechStar Acquisition Corporation on the listing. TechStar Acquisition Corporation (TechStar), a special purpose acquisition company (SPAC), successfully...
Fenbi’s HK$198 Million Listing on The HKSE
Cooley advised the underwriters involved in the listing while Wilson Sonsini Goodrich & Rosati represented Fenbi. Fenbi, an internet-born test preparation company, proposed the listing of...
Helens’ US$342 Million IPO and Listing on the HKSE
Wilson Sonsini Goodrich & Rosati advised Helens International Holdings Company Limited on the deal, while Davis Polk advised the underwriter. Helens International Holdings Company Limited (Helens)...